"HIV-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte.
| Descriptor ID |
D015497
|
| MeSH Number(s) |
B04.820.650.589.650.350.400
|
| Concept/Terms |
HIV-1- HIV-1
- Human immunodeficiency virus 1
- HIV-I
- Immunodeficiency Virus Type 1, Human
- Human Immunodeficiency Virus Type 1
|
Below are MeSH descriptors whose meaning is more general than "HIV-1".
Below are MeSH descriptors whose meaning is more specific than "HIV-1".
This graph shows the total number of publications written about "HIV-1" by people in this website by year, and whether "HIV-1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1996 | 1 | 0 | 1 |
| 1997 | 7 | 0 | 7 |
| 1998 | 11 | 0 | 11 |
| 1999 | 5 | 0 | 5 |
| 2000 | 4 | 0 | 4 |
| 2001 | 3 | 2 | 5 |
| 2002 | 6 | 2 | 8 |
| 2003 | 8 | 2 | 10 |
| 2004 | 4 | 0 | 4 |
| 2005 | 3 | 0 | 3 |
| 2006 | 2 | 0 | 2 |
| 2007 | 4 | 1 | 5 |
| 2008 | 1 | 2 | 3 |
| 2009 | 4 | 1 | 5 |
| 2010 | 2 | 0 | 2 |
| 2011 | 13 | 2 | 15 |
| 2012 | 6 | 4 | 10 |
| 2013 | 5 | 2 | 7 |
| 2014 | 4 | 1 | 5 |
| 2015 | 4 | 2 | 6 |
| 2016 | 8 | 1 | 9 |
| 2017 | 4 | 6 | 10 |
| 2018 | 4 | 1 | 5 |
| 2019 | 2 | 1 | 3 |
| 2020 | 3 | 4 | 7 |
| 2021 | 2 | 0 | 2 |
| 2022 | 6 | 0 | 6 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HIV-1" by people in Profiles.
-
An Efficient Humanized Mouse Model for Oral Anti-Retroviral Administration. Cells. 2023 03 28; 12(7).
-
Utility of the Signal-to-Cutoff Ratio and Antigen Index from Fourth- and Fifth-Generation HIV-1/HIV-2 Antigen/Antibody Assays for the Diagnosis of Acute HIV Infection: Applicability for Real-Time Use for Immediate Initiation of Antiretroviral Therapy. J Clin Microbiol. 2022 12 21; 60(12):e0120422.
-
Long-Acting Formulations for the Prevention and Treatment of Human Immunodeficiency Virus (HIV)-1 Infection: Strategic Leveraging and Integration of Multidisciplinary Knowledge to Advance Public Health. Clin Infect Dis. 2022 Nov 21; 75(Supplement_4):S498-S501.
-
The effect of induction immunosuppression for kidney transplant on the latent HIV reservoir. JCI Insight. 2022 11 08; 7(21).
-
Cocaine Self-Administration Influences Central Nervous System Immune Responses in Male HIV-1 Transgenic Rats. Cells. 2022 08 04; 11(15).
-
CD4dim CD8bright T Cells Home to the Brain and Mediate HIV Neuroinvasion. J Virol. 2022 08 10; 96(15):e0080422.
-
Editorial: Advances in T Cell Therapeutic Vaccines for HIV. Front Immunol. 2022; 13:905836.
-
Anti-HIV Drugs Cause Mitochondrial Dysfunction in Monocyte-Derived Macrophages. Antimicrob Agents Chemother. 2022 04 19; 66(4):e0194121.
-
?-catenin regulates HIV latency and modulates HIV reactivation. PLoS Pathog. 2022 03; 18(3):e1010354.
-
HIV and Aging in the Era of ART and COVID-19: Symposium Overview. J Acquir Immune Defic Syndr. 2022 02 01; 89(Suppl 1):S3-S9.